Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 Bekeken
• 08/09/23
0
0
insluiten
administrator
abonnees
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties